Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05853887
NA

Liquid Biopsy Based NGS in Newly Diagnosed NSCLC

Sponsor: Charu Aggarwal

View on ClinicalTrials.gov

Summary

This study expands the application of an electronic health record (EHR) "nudge" used to prompt physicians' clinical practice to order molecular testing at the time of initial diagnosis for patients with specific types of advanced lung cancer. The primary goal is to have these test results available prior to starting treatment so that physicians can make molecularly-informed treatment decisions. The second goal is to better understand factors that contribute to whether or not the EHR-nudge implementation is successful.

Official title: iNUDGE: INtegration of liqUiD Biopsy Based Next Generation Gene sEquencing in Newly Diagnosed NSCLC - A Stepped Wedge Cluster Randomized Clinical Trial

Key Details

Gender

All

Age Range

Any - Any

Study Type

INTERVENTIONAL

Enrollment

260

Start Date

2023-06-15

Completion Date

2026-12-31

Last Updated

2026-03-11

Healthy Volunteers

No

Interventions

BEHAVIORAL

iNUDGE

Electronic health record nudge which prompts physicians to order plasma-based NGS testing for eligible patients with newly diagnosed lung cancer.

Locations (6)

Penn Medicine Cherry Hill

Cherry Hill, New Jersey, United States

Penn Medicine Princeton Health

Plainsboro, New Jersey, United States

Penn Medicine Washington Township

Sewell, New Jersey, United States

Penn Medicine Voorhees

Voorhees Township, New Jersey, United States

Penn Medicine Lancaster General Health

Lancaster, Pennsylvania, United States

Penn Presbyterian Medical Center

Philadelphia, Pennsylvania, United States